Exjade is the first ORAL iron-chelation therapy

Exjade is the first ORAL iron-chelation therapy.

Exjade will be used in patients who develop iron overload from blood transfusions for sickle cell disease, thalassemia, etc...to prevent toxicity from high iron levels.

Until now, getting rid of excess iron required numerous Desferal (deferoxamine) infusions...but these can be very inconvenient.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote